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Abstract: Photoacoustic (PA) technology holds great potential in clinical translation as a new
non-invasive bioimaging modality. In contrast to conventional optical imaging, PA imaging (PAI)
enables higher resolution imaging with deeper imaging depth. Besides applications for diagnosis,
PA has also been extended to theranostic applications. The guidance of PAI facilitates remotely
controlled drug delivery. This review focuses on the recent development of PAI-mediated drug
delivery systems. We provide an overview of the design of different PAI agents for drug delivery.
The challenges and further opportunities regarding PA therapy are also discussed.
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1. Introduction
Photoacoustic (PA) technology has emerged as a promising imaging modality that has attracted
increasing interest for biomedical applications during the past decades [1–4]. The PA effect, first
discovered by Alexander G. Bell in 1880 [5,6], describes the formation of acoustic waves following
absorption of light pulses. More than a century after the discovery of the PA effect, photoacoustic
imaging (PAI) was introduced to biomedical applications. Since the pioneering work by Wang et al.
that realized in vivo PAI in a rat brain in 2003 [7], non-invasive PAI has been extensively explored as
a technology for biomedical imaging and diagnostics [8–13]. The mechanism of PAI is based on the
energy transformation among light, heat and sound (Figure 1). When illuminated with a pulsed laser,
PAI contrast agents in tissue rapidly absorb energy and generate heat causing thermalelastic expansion
and emitting mechanical pressure waves at ultrasonic frequencies. The periodic sound waves can
be detected by pressure transducers close to the tissue and output to form images. This imaging
mechanism endows deeper tissue penetration up to 5–6 cm as compared to the traditional optical
imaging modalities that have limited imaging depth within 1 mm [14]. In addition, PAI imaging offers
higher spatial resolution up to 5 µm, due to the weaker scattering of ultrasonic signals as compared to
light signals [15–18].
Certain endogenous molecules, such as hemoglobin and melanin, can function as PAI agents
due to the inherent optical absorption of these molecules [2]. Exogenous imaging agents with
high sensitivity and specificity have been widely exploited to further enhance the imaging signal,
especially those materials with strong absorption in the near-infrared (NIR) region where optical
attenuation is weaker than the visible light region in vivo. In addition to endogenous molecules,
many optical nanomaterials exhibit potential as PAI agents, including metallic nanoclusters,
carbon-based nanostructures, organic dyes, and conducting polymeric nanoparticles [17,19–21].
To date, PAI technology has demonstrated great potential in preclinical and clinical diagnosis of
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cancer [22–25], detection of tumor metastases [26,27], endoscopic gastrointestinal imaging [28],
and monitoring of treatments [29].
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Figure 1. Schematic illustration of photoacoustic imaging and drug delivery. 
Recently, the application of PAI has been extended to imaging-guided photothermal and 
chemotherapy. The PAI contrast agents that have strong absorbance in the NIR region can usually 
produce heat under laser irradiation, leading to thermal ablation and subsequent death of targeted 
cells, which is also termed photothermal therapy (PTT) [30]. Numerous agents have been developed 
to effectively increase the local temperature from the normal body temperature (37 °C) to over 41 °C 
to cause hyperthermia treatments, including protein denaturation and cell inactivation; or even up 
to 48 °C, leading to irreversible thermal damage [31]. The generated local hyperthermia can further 
promote encapsulated therapeutics diffusion from the agents, as well as facilitate cellular uptake as 
a result of increased membrane permeability for enhanced chemotherapy [32,33]. It was reported that 
the ultrasonic pressure produced by PA effect could be used to promote transdermal drug delivery, 
as well as localized drug release in vessels [34–36]. Researchers have also explored PAI agents as drug 
carriers, where the heat generated by the agent upon laser irradiation can control the drug release in 
an on-demand manner. In this review, we summarize the latest advances in PAI-assistant therapy 
and discuss representative examples of different material-based drug delivery systems. 
2. Inorganic Nanomaterials-Based Photoacoustic Therapy 
Among the inorganic materials that have been explored, metal nanomaterials such as noble 
metal (Au, Pd) nanoparticles [37–40] and transition metal dichalcogenides (WS2, TiS2, WOx, Cu2-xSe) 
[41–48] have attracted a great deal of attention in PAI application, owing to their desirable optical, 
chemical and biological properties. Another typical class of PAI agents is carbon-based nanomaterials, 
which include carbon nanotube and reduced graphene oxide [49–52]; and these materials possess 
strong optical absorption. In addition, this class has been investigated as drug carriers via 
functionalization or integration with other materials for PAI guided therapy [52]. The following 
section provides an overview of the most recent development of inorganic materials for use as both 
PAI contrast agents and therapeutic carriers. 
2.1. Metallic Nanomaterials 
Gold-based (Au) nanostructures comprise another dominant class of PAI contrast agents. Gold 
nanostructures, such as nanorods (NRs) [44,53–55], nanocages (NCs) [37,56–58], and nanospheres 
(NSs) [59], have strong and tunable optical absorption due to localized surface plasmon resonance 
(LSPR) effect, where the free charges on the surface of the Au nanostructures oscillate with the 
electromagnetic field. Additionally, the absorption region can be adjusted as a result of change in 
resonance frequency by modulating the size and shape of the Au nanostructures [60]. 
Numerous reports have demonstrated that Au nanostructures may be designed as drug carriers 
for PAI-guided chemo/photothermal therapy (PTT) [20,21,37,61–63]. For example, Wilson et al. 
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Numerous reports have demonstrated that Au nanostructures may be designed as drug carriers
for PAI-guided chemo/photothermal therapy (PTT) [20,21,37,61–63]. For example, Wilson et al.
developed liquid perfluorocarbon nanodroplet-encapsulated Au NRs as a PA and ultrasound imaging
agent, as well as a potential drug carrier (Figure 2) [64]. The heat generated by Au NRs under laser
causes the perfluorocarbon to undergo a phase transition (liquid-to-gas), resulting in subsequent
loading release. The researchers found that the PA signal was enhanced due to the vaporization of
perfluorocarbon as compared to the signal from Au NRs that were produced thermal expansion only.
Taking advantage of this design, the Xing group loaded paclitaxel and Au NRs into perfluorohexane
nanodroplets for PAI-guided chemotherapy and additionally functionalized the nanodroplets with
folic acid for tumor targeting [65]. Upon application of a pulsed laser, the nanodroplets were rapidly
destroyed due to the vaporization of perfluorohexane, resulting in rapid drug release. Researchers have
demonstrated enhanced tumor suppression as a result of photoacoustic-chemo synergistic treatment,
where the integration of chemotherapy with PTT not only achieved controlled and localized drug
release, but also promoted the cellular uptake, thus leading to improved therapeutic efficacy. Moreover,
the chemotherapy was shown to suppress tumor recurrence and metastasis that may be caused by
inhomogeneous ablation with PTT alone.
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Duan et al. designed a multimodal imaging-guided combination therapy system based on Au 
NRs [66]. The researchers first coated the Au NRs with mesoporous silica for loading of drug and 
quantum dots, and further decorated the system with adamantyl (Ad) groups and two-armed 
ethanolamine-modified poly(glycidyl methacrylate) with cyclodextrin cores (CD–PGEA) conjugates 
as gatekeeper (Figure 3). Additionally, pDNA was condensed to the surface of the nanostructure for 
gene therapy. The obtained ASQ-DOX-PGEA2-p53 (Au NRs@SiO2-QDs (quantum dots)/DOX 
(doxorubicin)-Ad/CD-PGEA2/p53) nanoplatform was designed to serve as modality for fluorescent 
imaging, CT imaging, as well as PAI, with the additional advantageous photothermal properties to 
effectively inhibit glioma tumor growth with application of NIR. Furthermore, the heat generated by 
Au NRs under NIR irradiation reduced the supramolecular interactions between Au and CD-PGEA, 
thereby opening the pore gate and leading to subsequent release of pDNA and DOX encapsulated in 
the mesoporous silica layer. Such multifunctional nanoparticles, integrating An NRs, silica layers, 
QDs, and CD-PGEA as one structure, leveraged the advantages of each component to realize precise 
imaging-guided gene/chemo/photothermal triple-combination therapy of cancer. Besides coating Au 
NRs with mesoporous silica, Huang et al. designed a ”yolk-shell” structure, incorporating a “non-
contact” porous magnetic nanoshell on Au NRs functioning as both the drug container and magnetic 
resonance imaging (MRI) agent [67]. Under the guidance of PAI and MRI, the drug carriers were 
magnetically guided to the tumor site with on-demand drug release triggered by pH/NIR. The 
synergistic chemo-photothermal therapy was shown to be effective in eradiating and suppressing 
recurrence of 4T1 tumor in mice. 
Figure 2. Schematic of Au NRs and therapeutics loading perfluorocarbon nanodroplet as PAI contrast
agent. (a) Diagram showing structure of the PA nanodroplet; (b) Illustrations indicating the mechanism
of PA activation of nanodroplet. @2011 Nature Publish Group [64].
Duan et al. designed a multimodal imaging-guided combination therapy system based on
Au NRs [66]. The researchers first coated the Au NRs with mesoporous silica for loading of drug
and quantum dots, and further decorated the system with adamantyl ( d) groups and t o-ar ed
ethanolamine-modified poly(glycidyl methacrylate) with cyclodextrin cores (CD–PGEA) conjugates
as gatekeeper (Figure 3). Additionally, pDNA was condensed to the surface of the nanostructure
for gene therapy. The obtained ASQ-DOX-PGEA2-p53 ( u Rs Si - s (quantu dots)/DOX
(doxorubicin)-Ad/C -P E 2/p53) nanoplatfor as designed to serve as odality for fluorescent
imaging, CT i aging, as ell as P I, ith the additional advantageous photother al properties to
effectively inhibit glioma tumor growth with application of IR. Furthermore, the heat generated by
Au NRs under IR irradiation reduced the supra olecular interactions bet een u and C -P E ,
thereby opening the pore gate and leading to subsequent release of pDNA and DOX encapsulated
in the mesoporous silica layer. Such multifunctional nanoparticles, integrating n Rs, silica layers,
QDs, and C -PGEA as one structure, leveraged the advantages of each co ponent to realize precise
imaging-guided gene/che o/photother al triple-co bination therapy of cancer. Besides coating Au
NRs with mesoporous silica, Huang et al. designed a “yolk-shell” structure, incorporating a “non-contact”
porous magnetic nanoshell on Au NRs functioning as both the drug container and magnetic resonance
imaging (MRI) agent [67]. Under the guidance of PAI and MRI, the drug carriers were magnetically guided
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to the tumor site with on-demand drug release triggered by pH/NIR. The synergistic chemo-photothermal
therapy was shown to be effective in eradiating and suppressing recurrence of 4T1 tumor in mice.
Alternatively, Lee et al. employed hollow Au nanopheres (HAuNSs) as both the drug carrier and
PAI agent [68]. The prepared DOX@ PEG (poly(ethylene glycol))-HAuNSs was shown to initiate the
release of DOX upon application of a 3-W NIR laser. In vivo experiments with PAI at tumor site also
revealed a substantial increase in temperature from 37 ◦C to more than 50 ◦C with laser irradiation, thereby
inducing effective photothermal ablation to inhibit tumor growth. Xia group designed a hybrid system
for bioimaging and therapy by integrating Au NCs with phase-change material (PCM) [69]. These Au
NCs were shown to function as a contrast agent for enhanced PAI, while the PCM, 1-tetradecanol, acted
as the drug reservoir for controlled release in response to heat. When the local temperatures surpassed
the melting point of the PCM, drug was able to diffuse through Au NCs.
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Cai et al. employed hollow mesoporous Prussian blue nanoparticles (HMPBs) as a PAI contrast 
agent [70]. Prussian blue, which is widely used in clinical medicine, has strong optical absorbance in 
NIR region owing to the charge transition between Fe(II) and Fe(III). Recently, Prussian blue has 
attracted increasing interest for use in PAI and PTT [71–74]. In this theranostic work, the researchers 
embedded perfluoropentane and DOX in HMPBs to form a versatile platform that could deliver DOX 
under the guidance of PA/ultrasound dual mode imaging and realize on-demand chemo/thermal 
therapy. To enhance the blood circulation time of HMPBs for improved anticancer efficacy, Chen et 
al. camouflaged the HMPBs by coating the system with an additional layer of the red blood cell 
membrane [75]. The red blood cell membrane on the surface was shown to effectively protect the 
HMPBs from body clearance. After 24 h-injection, 17.5% per injected dose per gram of tissue (ID/g) 
of coated HMPBs were still maintained in blood circulation, in contrast to the 6% of bare HMPBs 
remaining in circulation at the same time point. In addition, the coating of red blood cell membrane 
had the advantage of minimizing immune response. 
In addition to noble metallic nanoparticles, transition metal based nanomaterials also exhibit 
intriguing PA properties. Oxygen deficient molybdenum oxide (MoO3-x) nanocrystals are one of the 
typical nonstoichiometric metal chalcogenides, which possess significant LSPR absorption in the NIR 
region via certain specific synthesis process [76]. Bao et al. employed poly(ethylene glycol) (PEG) 
functionalized MoO3-x hollow nanospheres (PEG-MoO3-x HNSs) as a PAI agent for imaging-guided 
Figure 3. Schematic illustration of PAI-guided gene/chemo/photothermal triple therapy based on
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Cai et al. employed hollow mesoporous Prussian blue nanoparticles (HMPBs) as a PAI contrast
agent [70]. Prussia blue, which is widely us d in clinical medicine, has strong optical absorbance
in NIR region owing to the charge transition between Fe(I ) and Fe(III). Recently, Prussi n blue has
attracted increasing interest for use in PAI and PTT [71–74]. In this theranostic work, the esearchers
embedded perfluoropentane and DOX in HMPBs to form a versatile platfor that could deliver DOX
under the guidance of PA/ultrasound dual mode imaging and realize on-demand chemo/thermal
therapy. To enhance the blood circulation time of HMPBs for improved anticancer efficacy, Chen et al.
camouflaged the HMPBs by coating the system with an additional layer of the red blood cell
membrane [75]. The red blood cell membrane on the surface was shown to effectively protect the
HMPBs from body clearance. After 24 h-injection, 17.5% per injected dose per gram of tissue (ID/g)
of coated HMPBs w re still ai tained in blo d circulation, in contrast to the 6% of bare HMPBs
remaining in circula io at the s me time po nt. In ddition, the coating of red blood cell membrane
had the advantage of minimizin immune response.
In addition to noble metallic nanoparticles, transition metal based nanomaterials also exhibit
intriguing PA properties. Oxygen deficient molybdenum oxide (MoO3−x) nanocrystals are one
of the typical nonstoichiometric metal chalcogenides, which possess significant LSPR absorption
in the NIR region via certain specific synthesis process [76]. Bao et al. employed poly(ethylene
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glycol) (PEG) functionalized MoO3−x hollow nanospheres (PEG-MoO3−x HNSs) as a PAI agent for
imaging-guided chemo-photothermal therapy [77]. The PEG not only functioned as a stabilizer
to prevent MoO3−x HNSs from aggregation, but also shifted the LSPR absorption peak from
visible to NIR range due to its reduction function. Camptothecin, an insoluble anticancer drug,
was then encapsulated in the nanosphere, where its release kinetics was shown to be effectively
controlled by pH and NIR. The in vivo study showed remarkable synergism in the anticancer effect
inpancreatic tumor-bearing mice. Song et al. have also reported cobalt chalcogenides materials as
the theranostic agent, achieved by acrylic acid conjugated Co9Se8 nanoplate of 100 nm in diameter
and 6 nm in height [46]. With 10 min laser exposure (808 nm, 1 W/cm2), the PAA-Co9Se8 solution
(30 µg/mL) increased the temperature by 26 ◦C. DOX was further loaded to the nanoplates via
hydrophobic interactions with a pH-dependent and laser-triggered release dynamics for chemotherapy.
The nanoplates exhibited strong NIR absorbance and low toxicity, suggesting promise for this system
as a PAI contrast agent as well as a candidate for PTT.
2.2. Carbon-Based Nanostructures
Carbon nanotube exhibits strong optical absorbance from visible to NIR regions, making it a robust
PAI contrast agent [50,51,78,79]. It is also able to produce effective heat for photothermal ablation [80–82].
In addition, carbon nanotubes can also be used to load and deliver therapeutics for
chemotherapy [83]. To this end, Liu and coworkers exploited a NIR-triggered drug delivery system
based on mesoporous silica coated single wall carbon nanotube (SWNT) for diagnosis and therapy of
tumors (Figure 4), demonstrating accumulation of drug carriers in tumor via PAI and MRI [84].
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Figure 4. Schematic of PAI-guided chemo/photothermal therapy based on mesoporous silica coated
SWNTs. (a) Diagram showing preparation of DOX loading mesoporous silica modified SWNT;
(b) A scheme of NIR-triggered intracellular DOX release from SWNT; (c) Temperature change curves
of tumors with SWNT@MS-PEG under 808 nm laser irradiation of 0.5 W/cm2 for 20 min showing
effective heat generation (left); The NIR-triggered DOX release profiles (middle); Tumor growth curves
of mi e with different treatment indicating synergistic tumor inhibition effect by chemo/photothermal
therapy using SWNT@MS/DOX(Laser+) (right). @2015 Wiley [84].
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The SWNT was coated with mesoporous silica (MS) for drug loading, and further PEG function
on the surface for protection from fast body clearance (Figure 4a). The SWNT rapidly increased the
tumor surface temperature to ~48 ◦C and maintained during the laser irradiation (808 nm, 0.5 W/cm2
for 20 min) as monitored by an infrared thermal camera (Figure 4c). The local hyperthermia generated
by SWNT under NIR promoted rapid therapeutic release, resulting in a synergistic cancer cell killing
efficacy by the integration of chemo and photothermal therapy (Figure 4b). As presented in the tumor
growth curves (Figure 4c), the PTT (SWNT@MS-PEG(L+) group) could inhibit tumor growth partially,
even better than the chemotherapy (DOX group), contributing to the effective photothemal effect on
cell killing. However, the SWNT@MS-PEG/DOX(L+) group showed remarkably enhanced tumor
suppression effect than PTT only as a result of synergistic therapy.
Reduced graphene oxide (rGO) can also absorb light, while it has relatively low photothermal
conversion efficiency. Its optical properties can be improved via integration with other plasmonic
materials [48,85–88]. Chen and Ma group reported enhanced photothermal effect via coating
a plasmonic Au shell on rGO [89]. The Au nanorod vesicle (NRVe) was self-assembled by amphiphilic
PEG-grafted Au NRs, which functioned as a cavity that concentrated the electromagnetic radiations
and resulted in raised photo absorption. Anticancer drug DOX was then loaded on rGO by pi-pi
stacking interaction. With a relatively low laser irradiation (808 nm, 0.25 W/cm2), the rGO-Au
NRVe-DOX produced effective heat at the tumor site, promoting targeted drug release to tumor cells.
3. Organic Nanomaterials-Based Photoacoustic Therapy
In the realm of organic materials, small molecule dyes and semiconducting polymeric nanoparticles
have recently emerged as a new class of PAI agents [90–97]. These materials have been extensively
developed and also applied on theranostic platforms [98–104].
For example, Liu group encapsulated an NIR dye IR825, and a photosensitizer (chlorin e6)
in nanomicelles as PAI agent for imaging guided PTT and photodynamic therapy (PDT) [105].
The NIR dye accumulated at tumor sites absorbed photon energy and converted it to heat, inducing
a photothermal effect to inhibit tumor expression. The photosensitizer enabled transformation of
photo energy to the surrounding oxygen molecules, generating reactive oxygen species, such as
singlet oxygen (1O2), to kill cells, which is named PDT. Wang et al. designed a pH-responsive micelle
comprised of a pH-sensitive diblock polymer, the photosensitizer chlorin e6, and a pluronic prodrug
of DOX [106]. Under acidic conditions (pH < 6.3), the photoactivity was activated and was shown to
generate reactive oxygen species under NIR exposure to initiate drug release and PDT. The micelle also
transferred light to heat, thereby inducing local hyperthermia for PTT as well as functioning as a PAI
contrast agent. Cai et al. designed an organic PAI agent via self-assembly of a donor-acceptor-donor
(D-A-D) small molecule base on diketopyrrolopyrrole-triphenylamine [107]. The formation of particles
enhanced the D-A-D structure, which promoted charge transport capacity and generated heat upon
laser irradiation (660 nm, 1 W/cm2), as was shown to be efficient for tumor inhibition as a result of
PTT/PDT synergistic therapy. Recently, Zhang et al. synthesized an electron donor-acceptor (D-A)
conjugated polymer for light absorption [108]. They further introduced a light-harvesting unit to the
side chain in order to enhance photothermal conversion. The polymeric nanoparticles prepared using
nanoprecipitation methods exhibited effective PAI-guided PTT, reaching a photothermal conversion
efficiency of 62.3%. Taken together, these studies illuminate the potential of small organic nanoparticles
for PAI-guided therapy.
The Cheng group took advantage of an endogenous PAI agent, melanin, to fabricate PA
nanoparticles [109]. Melanin is a natural biopolymer that exists in many organisms and possesses
intrinsic PA properties in addition to ideal properties for molecular imaging, including good
biocompatibility and biodegradability [110]. The researchers synthesized ultra-small melanin
nanoparticles (MNPs) with a size of around 7 nm, which can be utilized for PAI due to its native optical
properties. In addition, the resulting MNPs were shown to actively chelate to metal ions such as Cu2+,
Fe3+ for magnetic resonance imaging (MRI) and positron emission tomography (PET). They further
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loaded a hydrophobic drug, sorafenib (SRF), on PEG-functionalized MNPs via pi–pi interactions
and formed a larger MNPs aggregate with a size of 60 nm for imaging-guided chemotherapy [111].
Subsequent in vivo studies indicated that the SRF-MNPs successfully transported drug into tumor via
intravenous injection and required much lower dose (4 mg kg−1) as compared to oral administration
(20 mg kg−1).
With the assistance of a transducer that comprised of a laser absorption layer (carbon nanotube)
and a thermal expansion layer (polydimethylsiloxane), pulsed laser can be transmitted to high
frequency ultrasound [112]. The Gu and Jiang groups utilized laser-generated-focused ultrasound
(LGFU) to trigger drug release from the microgel (Figure 5) [36]. Compared to traditional ultrasound
triggered drug delivery systems, LGFU showed higher resolution and reduced heating effect to
normal tissue. Anticancer drug DOX and antibacterial drug ciprofloxacin were encapsulated in
PLGA nanoparticles, after which the PLGA nanoparticles were further embedded into alginate
microgel. A significantly enhanced release of drug was observed at the focal spot after application of
LGFU by the cavitation effect. The researchers further validated that this LGFU-triggered delivery
device could be leveraged to provide spatiotemporally controlled release for in vitro antitumor and
antibacterial treatment.
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4. Conclusions
In summary, PAI technology has been developed rapidly in the past decades and continues to
see substantial expansion of capabilities and refinement of technique. Furthermore, PAI-assisted
drug delivery systems have displayed promising evidence of synergistic treatment efficacy. However,
such systems still face multiple challenges in terms of clinical translation. For instance, although
metallic nanoparticles exhibit excellent and tunable optical properties, there are concerns with
regards to their systemic cytotoxicity in long-term treatment. Therefore, further investigations into
biocompatibility are critically needed. Although small molecular dyes offer better biocompatibility
and relatively low cost-two benefits which have conferred wide application of these systems in
biomedicine-poor photostability and short retention time are two limitations that need to be addressed
prior to translational studies. Semiconducting polymer particles have emerged as alternative PAI
agents with enhanced stability [113], yet their relatively complicated and costly preparation process
represents a barrier for further translation. The study of improvement upon these limitations will
ultimately allow PA technology to move forward as a competitive non-invasive bioimaging and
treatment modality in clinic [114,115].
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